期刊文献+

蛇床子素在Caco-2细胞模型中的转运机制研究 被引量:5

Study on Transport Mechanisms of Osthol in Caco-2 Cell Model
原文传递
导出
摘要 目的研究蛇床子素在Caco-2细胞模型中的转运机制。方法通过研究蛇床子素在Caco-2细胞模型中的转运,考察蛇床子素浓度、PEG600、P-gp抑制剂维拉帕米(verapamil)及温度对蛇床子素转运的影响。结果随着蛇床子素溶液浓度和温度的升高,蛇床子素在Caco-2细胞中AP-BL的转运量增加;PEG600对蛇床子素在Caco-2细胞中的AP-BL的转运量有显著增加;P-gp抑制剂维拉帕米对蛇床子素在Caco-2细胞中转运的表观通透系数PAP和PBL无显著影响。结论蛇床子素表观通透系数PAP大于10×10-6cm.s-1,较易被Caco-2细胞吸收,但由于3个浓度蛇床子素溶液的PAP和PBL比值无明显变化、P-gp抑制剂对PAP和PBL无明显影响及转运的活化能较低(17.31 kJ.mol-1),因此,蛇床子素在Caco-2细胞模型中的转运机制主要是被动转运。 OBJECTIVE To study the transport mechanisms of osthol by using Caco-2 cell model. METHODS The effect of concentration, PEG600, verapamil (P-gp inhibitor)and temperature on transport of osthol in Caco-2 cell model was studied. RESULTS Osthol amount transported in the apical(AP) to basolateral(BL) in Caco-2 cell cell model was increased with loading concen- tration and temperature. PEG600 enhanced the rate of osthol transport. The PAP and PBLOf osthol in Caco-2 model were not affected by verapamil. CONCLUSION The PAP of osthol in Caco-2 model was above 10 x 10-6 and osthol was absorbed easily by Caco-2 cell. Further, there were no significant differences in the ratios of P^L to PAP at three concentrations. Activation energy was quite moderate at 17. 31 kJ · mol^-1. The ratio of PBL to PAP of osthol transport were not affected by verapamil, suggesting that the absorption is via passive diffusion.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第4期278-282,共5页 Chinese Pharmaceutical Journal
关键词 蛇床子素 CACO-2细胞模型 维拉帕米 微粒体 高效液相色谱法 osthol caco-2 cell model verapamil microsomes HPLC
  • 相关文献

参考文献6

二级参考文献22

  • 1吴孟华,黄朝瑜,赵陆华,梅玲华.蛇床子药材高效液相色谱指纹图谱的研究[J].中国天然药物,2005,3(2):106-111. 被引量:8
  • 2李青南,梁念慈,吴铁,吴怡,谢华,黄国栋,莫丽儿.蛇床子总香豆素对去卵巢骨骼的影响(英文)[J].中国药理学报,1994,15(6):528-532. 被引量:23
  • 3严申彪 张继明(等).复方蛇床子洗剂的制备及应用[J].中国医院药学杂志,1998,18(8):374-374.
  • 4Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies: Animal model for human skin[J]. Toxicol Appl Pharmacol, 1982,62:481.
  • 5Harrison JE,Watkinson AC,Green DM,et al. The relative effect of Azone trandeutol on permeant diffusivity and solubility in human stratum comeum[ J ]. Pharm Res, 1996,13: 542.
  • 6Walter RB. Pharmaceutical Skin Penetration Enhancement[M].New York: Marcel Dekker,Inc,1993:l13.
  • 7陆彬.药物新剂型与新技术[M].北京:人民卫生出版社,2002.353-409.
  • 8Ch.P(2005)Vol Ⅰ (中国药典2005 年版.一部)[S].2005:219-220
  • 9State Administration of Traditional Chinese Medicine.Chinese Bencao(中华本草)[M].Vol 5.Shanghai:Shanghai Scientific and Technological Publisher,1998:928-933.
  • 10张新勇,向仁德.蛇床子化学成分的研究[J].中草药,1997,28(10):588-590. 被引量:39

共引文献102

同被引文献72

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部